A 10193

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Assembly
  • Senate
  • Governor

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists

Abstract

Includes all FDA approved forms and doses of Naloxone as opioid antagonists in the state definition of opioid antagonists; requires the department of health to approve all forms and doses of Naloxone approved by the FDA as opioid antagonists.

Bill Sponsors (1)

Rules Committee

     
Primary

Votes


No votes to display

Actions


Sep 06, 2024

Assembly

ENACTING CLAUSE STRICKEN

May 10, 2024

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A10193 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.